
Pluristem Therapeutics PSTI
Quartalsbericht 2025-Q4
hinzugefügt 12.02.2026
Pluristem Therapeutics P/S 2011-2026 | PSTI
P/S Jährlich Pluristem Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.89 | 16.6 | 16.4 | 142 | - | 7.24 K | 1.28 K | 2.6 K | - | 41.4 | 440 | 478 | 248 | 205 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.24 K | 4.89 | 1.06 K |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Esperion Therapeutics
ESPR
|
1.39 | $ 3.13 | 0.39 % | $ 651 M | ||
|
Exelixis
EXEL
|
5.05 | $ 45.86 | 3.23 % | $ 12.5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Fortress Biotech
FBIO
|
1.23 | $ 2.51 | 2.03 % | $ 70 M | ||
|
Galapagos NV
GLPG
|
18.9 | $ 28.95 | 1.97 % | $ 2.69 B | ||
|
Genmab A/S
GMAB
|
15.6 | $ 27.7 | 0.59 % | $ 17.1 B | ||
|
Grifols, S.A.
GRFS
|
1.71 | $ 8.37 | 1.2 % | $ 6.83 B | ||
|
BioNTech SE
BNTX
|
35.7 | $ 94.84 | -0.69 % | $ 27.2 B | ||
|
Immuron Limited
IMRN
|
207 | $ 0.81 | 2.15 % | $ 6.7 M | ||
|
Ionis Pharmaceuticals
IONS
|
63.5 | $ 76.26 | 1.34 % | $ 12.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Kamada Ltd.
KMDA
|
2.61 | $ 8.25 | 0.49 % | $ 260 M | ||
|
INmune Bio
INMB
|
564 | $ 1.55 | 0.65 % | $ 38.4 M | ||
|
Kymera Therapeutics
KYMR
|
202 | $ 85.73 | 3.65 % | $ 7.24 B | ||
|
Kazia Therapeutics Limited
KZIA
|
21.9 | $ 12.98 | -3.49 % | $ 1.72 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
3.33 | $ 22.93 | 2.6 % | $ 3.8 B | ||
|
Liquidia Corporation
LQDA
|
18.6 | $ 42.33 | 5.48 % | $ 3.64 B | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 3.55 | 1.43 % | $ 5.84 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Mirum Pharmaceuticals
MIRM
|
10.4 | $ 107.42 | 1.52 % | $ 5.39 B | ||
|
MannKind Corporation
MNKD
|
2.84 | $ 4.01 | 40.03 % | $ 1.23 B | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 23.48 | 0.26 % | $ 2.99 B | ||
|
Nanobiotix S.A.
NBTX
|
98.9 K | $ 41.5 | 19.36 % | $ 286 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B |